{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:25:39Z","timestamp":1783347939934,"version":"3.54.6"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Society of Human Reproduction and Embryology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What are the trends and developments in preimplantation genetic testing (PGT) in 2019\u20132021 as compared to previous years?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>The main trend observed in the 22nd to 24th datasets on PGT is that the implementation of trophectoderm biopsy with comprehensive whole-genome testing is most often applied for PGT for aneuploidies (PGT-A) and concurrent PGT-M\/SR\/A, while for PGT for monogenic disorders (PGT-M) and PGT for chromosomal structural rearrangements (PGT-SR), single-cell targeted testing with PCR and FISH still prevails.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Since it was established in 1997, the PGT Consortium within the European Society for Human Reproduction (ESHRE) has been collecting and analysing data from mainly European PGT centres. To date, 21 datasets and an overview of the first 10\u2009years of data collections have been published.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>The data for PGT analyses performed between 1 January 2019 and 31 December 2021 with a 2-year follow-up, after analysis were provided by participating centres on a voluntary basis. Data were collected using an online platform; the data reported on a per genetic analysis basis as opposed to the former cycle-based database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Data on biopsy methods, diagnostic technologies, genetic diseases, and clinical outcomes were submitted by 45 centres. Records with multiple PGT-M and\/or PGT-SR analyses or inconsistent PGT data were excluded. Embryo transfers performed within 2\u00a0years of analysis were included to calculate clinical outcomes, including stratification by biopsy day and cumulative pregnancy rates. Data analysis, calculations, and preparation of figures and tables were carried out by expert co-authors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>A total of 14\u00a0731 PGT analyses were reported: 3782 for PGT-M, 874 for PGT-SR, 8492 for PGT-A, and 1583 for combined PGT-M\/SR with PGT-A, henceforth referred to as combined testing. The use of trophectoderm biopsy increased for PGT-M (33% in 2018 to 49% in 2019\u20132021), remained stable for PGT-SR (33\u201336%), and was consistently high for PGT-A (98%) and combined cases (96%). The adoption of genome-wide or targeted technologies following whole-genome amplification (WGA) remained relatively stable for PGT-M (12\u201314%) and PGT-SR (44\u201345%), while genome-wide analysis performed on whole-genome-amplified DNA became the standard for PGT-A (99%). The combination of PGT-M\/SR with PGT-A was performed either by applying a technology following WGA (74%) or by targeted methods (PCR or FISH, 24%). Diagnostic efficiency was 87% for PGT-M, 92% for PGT-SR, 98% for PGT-A, and 90% for combined testing. Pregnancy rates per embryo transfer were 26% for PGT-M, 26% for PGT-SR, 35% for PGT-A, and 36% for combined testing. Across all groups, Day 5 biopsies yielded better outcomes than Day 3 or Day 6 biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The findings refer to data submitted by 45 participating centres and do not reflect global trends in PGT. Information on the health of babies born following PGT was not included in this manuscript. It should also be noted that final outcomes may be influenced by the number and type of centres submitting data in different years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>The Consortium datasets provide a valuable resource for monitoring trends in PGT practice, both from a technological perspective and in terms of clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>The study has no external funding, and all costs are covered by ESHRE. There are no competing interests declared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>NA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deag081","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:25:28Z","timestamp":1777638328000},"page":"1050-1061","source":"Crossref","is-referenced-by-count":0,"title":["ESHRE PGT Consortium data collection XXII\u2013XXIV: PGT analyses from 2019 to 2021"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2108-7075","authenticated-orcid":false,"given":"F","family":"Spinella","sequence":"first","affiliation":[{"name":"Saint Camillus International University of Health Sciences, Via di Sant\u2019Alessandro , Rome,","place":["Italy"]},{"name":"Eurofins Genoma Group , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8889-1255","authenticated-orcid":false,"given":"D","family":"Christopikou","sequence":"additional","affiliation":[{"name":"IVIR , Thessaloniki,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-9426","authenticated-orcid":false,"given":"M","family":"De Rycke","sequence":"additional","affiliation":[{"name":"Clinical Sciences, Research group Genetics, Reproduction and Development, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1163-8742","authenticated-orcid":false,"given":"M","family":"Florensa","sequence":"additional","affiliation":[{"name":"IVIRMA Barcelona , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-8278","authenticated-orcid":false,"given":"M","family":"Heijligers","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Maastricht University Medical Centre (MUMC+) , Maastricht,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-3143","authenticated-orcid":false,"given":"C L F","family":"Toft","sequence":"additional","affiliation":[{"name":"Department of Molecular Diagnostics, Aalborg University Hospital , Aalborg,","place":["Denmark"]},{"name":"Center for Preimplantation Genetic Testing, Aalborg University Hospital , Aalborg,","place":["Denmark"]},{"name":"The Fertility Unit, Aalborg University Hospital , Aalborg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7463-7302","authenticated-orcid":false,"given":"E","family":"Constantinou","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics and Genomics, The Cyprus Institute of Neurology and Genetics , Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-3003","authenticated-orcid":false,"given":"S","family":"Viville","sequence":"additional","affiliation":[{"name":"Laboratoire de Diagnostic G\u00e9n\u00e9tique, H\u00f4pitaux Universitaires de Strasbourg, UF3472-G\u00e9n\u00e9tique de l\u2019infertilit\u00e9 , Strasbourg,","place":["France"]},{"name":"Institute for Genetics and Molecular and Cellular Biology (IGBMC), University of Strasbourg, CNRS UMR7104, INSERM U1258 , Illkirch,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9342-2143","authenticated-orcid":false,"given":"V","family":"Goossens","sequence":"additional","affiliation":[{"name":"ESHRE, Central Office , Strombeek-Bever,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-0057","authenticated-orcid":false,"given":"E","family":"Dimitriadou","sequence":"additional","affiliation":[{"name":"Centre for Human Genetics, University Hospitals Leuven , Leuven,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2026070609585361100_deag081-B1","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s10815-025-03582-7","article-title":"Euploidy rate and reproductive outcomes in embryos biopsied at days 5, 6, 7 and 8 of development: a multicenter study","volume":"42","author":"Abarca-Rodr\u00edguez","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"2026070609585361100_deag081-B2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10815-024-03305-4","article-title":"Assessing the clinical value of day 7 blastocysts: a predictive model for preimplantation genetic testing for aneuploidy (PGT-A) cycles","volume":"42","author":"Abdala","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"2026070609585361100_deag081-B3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/S0967199421000435","article-title":"The effects of the day of trophectoderm biopsy and blastocyst grade on the clinical and neonatal outcomes of preimplantation genetic testing-frozen embryo transfer cycles","volume":"30","author":"Chen","year":"2022","journal-title":"Zygote"},{"key":"2026070609585361100_deag081-B4","doi-asserted-by":"crossref","first-page":"hoaa043","DOI":"10.1093\/hropen\/hoaa043","article-title":"ESHRE PGT Consortium data collection XVI-XVIII: cycles from 2013 to 2015","volume":"2020","author":"Coonen","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2026070609585361100_deag081-B5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/humrep\/dev122","article-title":"ESHRE PGD Consortium data collection XIII: cycles from January to December 2010 with pregnancy follow-up to October 2011","volume":"30","author":"De Rycke","year":"2015","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/dex265","article-title":"ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013","volume":"32","author":"De Rycke","year":"2017","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/humrep\/17.1.233","article-title":"ESHRE Preimplantation Genetic Diagnosis Consortium: data collection III (May 2001)","volume":"17","author":"ESHRE PGD Consortium Steering Committee","year":"2002","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B8","doi-asserted-by":"crossref","first-page":"hoaa020","DOI":"10.1093\/hropen\/hoaa020","article-title":"ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT","volume":"2020","author":"ESHRE PGT Consortium and SIG-Embryology Biopsy Working Group","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2026070609585361100_deag081-B9","doi-asserted-by":"crossref","first-page":"hoac044","DOI":"10.1093\/hropen\/hoac044","article-title":"ESHRE survey results and good practice recommendations on managing chromosomal mosaicism","volume":"2022","author":"ESHRE Working Group on Chromosomal Mosaicism","year":"2022","journal-title":"Hum Reprod Open"},{"key":"2026070609585361100_deag081-B10","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/14.12.3138","article-title":"ESHRE Preimplantation Genetic Diagnosis (PGD) Consortium: preliminary assessment of data from January 1997 to September 1998","volume":"14","author":"Geraedts","year":"1999","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B11","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/humrep\/15.12.2673","article-title":"ESHRE Preimplantation Genetic Diagnosis (PGD) consortium: data collection II (May 2000)","volume":"15","author":"Geraedts","year":"2000","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B12","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/humrep\/den238","article-title":"ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006","volume":"23","author":"Goossens","year":"2008","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B13","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dep059","article-title":"ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007","volume":"24","author":"Goossens","year":"2009","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/humrep\/des106","article-title":"ESHRE PGD Consortium data collection XI: cycles from January to December 2008 with pregnancy follow-up to October 2009","volume":"27","author":"Goossens","year":"2012","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/humrep\/dei292","article-title":"ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003","volume":"21","author":"Harper","year":"2006","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B16","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/humrep\/deq228","article-title":"ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008","volume":"25","author":"Harper","year":"2010","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humrep\/dem354","article-title":"ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005","volume":"23","author":"Harper","year":"2008","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B158","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/humupd\/dmr052","volume":"18","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2026070609585361100_deag081-B18","doi-asserted-by":"crossref","first-page":"1544009","DOI":"10.3389\/fendo.2025.1544009","article-title":"Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomes","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026070609585361100_deag081-B19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/humrep\/deu012","article-title":"ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010","volume":"29","author":"Moutou","year":"2014","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.fertnstert.2017.03.024","article-title":"Detection of mosaicism at blastocyst stage with the use of high-resolution next-generation sequencing","volume":"107","author":"Munn\u00e9","year":"2017","journal-title":"Fertil Steril"},{"key":"2026070609585361100_deag081-B21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/humrep\/dead213","article-title":"Implicit bias in diagnosing mosaicism amongst preimplantation genetic testing providers: results from a multicenter study of 36\u2009395 blastocysts","volume":"39","author":"Popovic","year":"2024","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/humrep\/deh552","article-title":"ESHRE PGD Consortium data collection IV: May-December 2001","volume":"20","author":"Sermon","year":"2005","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/del402","article-title":"ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004","volume":"22","author":"Sermon","year":"2007","journal-title":"Hum Reprod"},{"key":"2026070609585361100_deag081-B24","doi-asserted-by":"crossref","first-page":"hoad010","DOI":"10.1093\/hropen\/hoad010","article-title":"ESHRE PGT Consortium data collection XXI: PGT analyses in 2018","volume":"2023","author":"Spinella","year":"2023","journal-title":"Hum Reprod Open"},{"key":"2026070609585361100_deag081-B25","doi-asserted-by":"crossref","first-page":"hoab024","DOI":"10.1093\/hropen\/hoab024","article-title":"ESHRE PGT Consortium data collection XIX-XX: cycles from 2016 to 2017","volume":"2021","author":"Van Montfoort","year":"2021","journal-title":"Hum Reprod Open"},{"key":"2026070609585361100_deag081-B26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/genes11060602","article-title":"Preimplantation genetic testing for chromosomal abnormalities: aneuploidy, mosaicism, and structural rearrangements","volume":"11","author":"Viotti","year":"2020","journal-title":"Genes (Basel)"},{"key":"2026070609585361100_deag081-B27","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/7\/1050\/68499920\/deag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/7\/1050\/68499920\/deag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:59:02Z","timestamp":1783346342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/7\/1050\/8704620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag081","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,9]]}}}